Unknown NA INTERVENTIONAL 2-arm NCT02649283

Performance of OrbiSymm in Subjects Referred to Contra Lateral Breast Symmetrisation

Phase IV, Multicenter, Open Label, Non Randomized Comparative Group Study to Assess the Safety and Performance of the OrbiSymm in Subjects Referred to Contra Lateral Breast Symmetrisation Following Breast Reconstruction Post Mastectomy

Sponsor: Orbix Medical Ltd.

Conditions Breast Asymmetry Between Native Breast and Reconstructed Breast

Interventions Breast symmetrisation OrbiSymm device

Updated 6 times since 2017 Last updated: Sep 28, 2016 Started: Oct 31, 2016 Primary completion: Oct 31, 2019 Completion: Oct 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Asymmetry Between Native Breast and Reconstructed Breast, this trial is ongoing. The trial is conducted by Orbix Medical Ltd. and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Nov 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Nov 2019 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Orbix Medical Ltd.

Data source: Orbix Medical Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy